From €119EUR$129USD£101GBP
- Newsletter
- May 2025
- 4 Pages
Global
From €184EUR$200USD£156GBP
- Report
- April 2025
- 43 Pages
United States
- Report
- January 2025
- 132 Pages
Global
From €876EUR$950USD£740GBP
- Report
- July 2024
- 132 Pages
Global
From €876EUR$950USD£740GBP
- Training
- 90 Minutes
Global
- Report
- November 2021
- 527 Pages
Global
From €3686EUR$4,000USD£3,117GBP
- Report
- November 2021
- 1184 Pages
Global
From €5530EUR$6,000USD£4,675GBP
- Report
- November 2021
- 802 Pages
Global
From €4608EUR$5,000USD£3,896GBP
- Report
- March 2022
- 257 Pages
Global
From €2395EUR$2,598USD£2,025GBP
€3421EUR$3,712USD£2,892GBP
- Report
- December 2024
- 300 Pages
Global
From €1713EUR$1,859USD£1,448GBP
€2447EUR$2,655USD£2,069GBP
- Report
- December 2024
- 321 Pages
Global
From €1713EUR$1,859USD£1,448GBP
€2447EUR$2,655USD£2,069GBP
- Report
- December 2024
- 423 Pages
Global
From €1713EUR$1,859USD£1,448GBP
€2447EUR$2,655USD£2,069GBP

Regenerative Medicine is a field of biotechnology that focuses on the development of treatments and therapies that can restore or replace damaged or diseased cells, tissues, and organs. It is based on the principles of stem cell biology, tissue engineering, and gene therapy. It has the potential to revolutionize the way diseases are treated, and to improve the quality of life for patients.
Regenerative Medicine is a rapidly growing field, with a wide range of applications. It is being used to treat a variety of conditions, including cardiovascular diseases, neurological disorders, and musculoskeletal injuries. It is also being used to develop treatments for cancer, diabetes, and other chronic diseases.
Some of the companies in the Regenerative Medicine market include Athersys, Inc., Celgene Corporation, Osiris Therapeutics, Inc., Vericel Corporation, and Organogenesis, Inc. Show Less Read more